Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are able and willing to give their informed consent to take part.
- People who are able to take part in all parts of this clinical study.
- Men and women aged 18 to 80 years old at the time of their screening visit.
- People who have been diagnosed with moderate to severe ulcerative colitis, confirmed by clinical assessment and an endoscopy.
- People who have never previously been treated with a type of medicine called a biological therapy.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously been treated with the medicines infliximab (IFX) or ustekinumab (UST), or any product containing these medicines.
- People who have a history of allergic reactions or sensitivity to the ingredients found in infliximab or ustekinumab.
- People who have unstable angina (a type of chest pain caused by reduced blood flow to the heart).
- People who have moderate or severe heart failure, classified as New York Heart Association Class III or IV (confirm with trial site).
- People who have chronic respiratory failure (long-term serious difficulty breathing).
- People who have a history of major neurological conditions, including stroke, multiple sclerosis, brain tumour, or a degenerative disease of the nervous system.
- People who have a chronic hepatitis B or C infection — though people with certain positive hepatitis B or C blood test results at screening may still be considered if a more specific follow-up test (polymerase chain reaction) is negative and they receive appropriate antiviral treatment if needed (confirm with trial site).
- People who are known to have severe long-term kidney failure.
- People who are known to have severe long-term liver failure.
- People who are known to have active or latent (inactive but present) tuberculosis.
- People who have an ongoing HIV infection.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
(CRP) and Improvement degree of ulcerative colitis; safety evaluation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.